Fertility and Sterility
Volume 94, Issue 7 , Pages 2772-2775 , December 2010

Sequence variation analysis of the prolactin receptor C-terminal region in women with premature ovarian failure

  • Anne Bachelot, M.D., Ph.D.

      Affiliations

    • Institut National de la Santé et de la Recherche Médicale, U845, Paris, France
    • Université Pierre et Marie Curie, Paris, France
    • Département d'Endocrinologie et Médecine de la Reproduction, Centre de référence des Maladies Endocriniennes rares de la croissance, Assistance Publique–Hôpitaux de Paris, Paris, France
    • ,
  • Justine Bouilly, B.Sc.

      Affiliations

    • Institut National de la Santé et de la Recherche Médicale, U845, Paris, France
    • Université Paris Descartes, Faculté de Médecine, Paris, France
    • ,
  • Yuchen Liu, B.Sc.

      Affiliations

    • Institut National de la Santé et de la Recherche Médicale, U845, Paris, France
    • Université Paris Descartes, Faculté de Médecine, Paris, France
    • ,
  • Diane Rebourcet, Ph.D.

      Affiliations

    • Institut National de la Santé et de la Recherche Médicale, U845, Paris, France
    • Université Paris Descartes, Faculté de Médecine, Paris, France
    • ,
  • Céline Leux, B.Sc.

      Affiliations

    • Institut National de la Santé et de la Recherche Médicale, U845, Paris, France
    • Université Paris Descartes, Faculté de Médecine, Paris, France
    • ,
  • Frédérique Kuttenn, M.D.

      Affiliations

    • Institut National de la Santé et de la Recherche Médicale, U845, Paris, France
    • Université Pierre et Marie Curie, Paris, France
    • Département d'Endocrinologie et Médecine de la Reproduction, Centre de référence des Maladies Endocriniennes rares de la croissance, Assistance Publique–Hôpitaux de Paris, Paris, France
    • ,
  • Philippe Touraine, M.D., Ph.D.

      Affiliations

    • Institut National de la Santé et de la Recherche Médicale, U845, Paris, France
    • Université Pierre et Marie Curie, Paris, France
    • Département d'Endocrinologie et Médecine de la Reproduction, Centre de référence des Maladies Endocriniennes rares de la croissance, Assistance Publique–Hôpitaux de Paris, Paris, France
    • ,
  • Nadine Binart, Ph.D.

      Affiliations

    • Institut National de la Santé et de la Recherche Médicale, U845, Paris, France
    • Université Paris Descartes, Faculté de Médecine, Paris, France
    • Corresponding Author InformationReprint requests: Nadine Binart, Ph.D., INSERM, U845, Faculté de Médecine Necker, 156 rue de Vaugirard, 75015 Paris, France (FAX: 331-40-61-55-87).

Received 25 March 2010 ,Revised 12 May 2010 ,Accepted 15 June 2010.

References 

  1. Beck-Peccoz P, Persani L. Premature ovarian failure. Orphanet J Rare Dis. 2006;1:9:1–5
  2. Goswami D, Conway GS. Premature ovarian failure. Horm Res. 2007;68:196–202
  3. Nelson LM. Clinical practice. Primary ovarian insufficiency. N Engl J Med. 2009;360:606–614
  4. Kim TJ, Anasti JN, Flack MR, Kimzey LM, Defensor RA, Nelson LM. Routine endocrine screening for patients with karyotypically normal spontaneous premature ovarian failure. Obstet Gynecol. 1997;89:777–779
  5. Rebar RW, Erickson GF, Yen SS. Idiopathic premature ovarian failure: clinical and endocrine characteristics. Fertil Steril. 1982;37:35–41
  6. Aittomaki K, Lucena JL, Pakarinen P, Sistonen P, Tapanainen J, Gromoll J, et al. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell. 1995;82:959–968
  7. Doherty E, Pakarinen P, Tiitinen A, Kiilavuori A, Huhtaniemi I, Forrest S, et al. A Novel mutation in the FSH receptor inhibiting signal transduction and causing primary ovarian failure. J Clin Endocrinol Metab. 2002;87:1151–1155
  8. Beau I, Touraine P, Meduri G, Gougeon A, Desroches A, Matuchansky C, et al. A novel phenotype related to partial loss of function mutations of the follicle stimulating hormone receptor. J Clin Invest. 1998;102:1352–1359
  9. Touraine P, Beau I, Gougeon A, Meduri G, Desroches A, Pichard C, et al. New natural inactivating mutations of the follicle-stimulating hormone receptor: correlations between receptor function and phenotype. Mol Endocrinol. 1999;13:1844–1854
  10. Meduri G, Touraine P, Beau I, Lahuna O, Desroches A, Vacher-Lavenu MC, et al. Delayed puberty and primary amenorrhea associated with a novel mutation of the human follicle-stimulating hormone receptor: clinical, histological, and molecular studies. J Clin Endocrinol Metab. 2003;88:3491–3498
  11. Di Pasquale E, Beck-Peccoz P, Persani L. Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene. Am J Hum Genet. 2004;75:106–111
  12. Gallardo TD, John GB, Bradshaw K, Welt C, Reijo-Pera R, Vogt PH, et al. Sequence variation at the human FOXO3 locus: a study of premature ovarian failure and primary amenorrhea. Hum Reprod. 2008;23:216–221
  13. Laissue P, Christin-Maitre S, Touraine P, Kuttenn F, Ritvos O, Aittomaki K, et al. Mutations and sequence variants in GDF9 and BMP15 in patients with premature ovarian failure. Eur J Endocrinol. 2006;154:739–744
  14. Di Pasquale E, Rossetti R, Marozzi A, Bodega B, Borgato S, Cavallo L, et al. Identification of new variants of human BMP15 gene in a large cohort of women with premature ovarian failure. J Clin Endocrinol Metab. 2006;91:1976–1979
  15. Lourenco D, Brauner R, Lin L, De Perdigo A, Weryha G, Muresan M, et al. Mutations in NR5A1 associated with ovarian insufficiency. N Engl J Med. 2009;360:1200–1210
  16. Rajkovic A, Pangas SA, Ballow D, Suzumori N, Matzuk MM. NOBOX deficiency disrupts early folliculogenesis and oocyte-specific gene expression. Science. 2004;305:1157–1159
  17. Zhao H, Chen ZJ, Qin Y, Shi Y, Wang S, Choi Y, et al. Transcription factor FIGLA is mutated in patients with premature ovarian failure. Am J Hum Genet. 2008;82:1342–1348
  18. Halperin J, Devi SY, Elizur S, Stocco C, Shehu A, Rebourcet D, et al. Prolactin signaling through the short form of its receptor represses forkhead transcription factor FOXO3 and its target gene alt causing a severe ovarian defect. Mol Endocrinol. 2008;22:513–522
  19. Davis JA, Linzer DH. Expression of multiple forms of the prolactin receptor. Mol Endocrinol. 1989;3:674–680
  20. Clevenger CV, Furth PA, Hankinson SE, Schuler LA. The role of prolactin in mammary carcinoma. Endocr Rev. 2003;24:1–27
  21. Hu ZZ, Meng J, Dufau ML. Isolation and characterization of two novel forms of the human prolactin receptor generated by alternative splicing of a newly identified exon 11. J Biol Chem. 2001;276:41086–41094
  22. Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA. Prolactin and its receptor: actions, signal transduction pathways and phenotypes observed in prolactin receptor knockout mice. Endocr Rev. 1998;19:225–268
  23. Castrillon DH, Miao L, Kollipara R, Horner JW, DePinho RA. Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a. Science. 2003;301:215–218
  24. Hosaka T, Biggs WH, Tieu D, Boyer AD, Varki NM, Cavenee WK, et al. Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification. Proc Natl Acad Sci U S A. 2004;101:2975–2980
  25. Forges T, Monnier-Barbarino P, Leheup B, Jouvet P. Pathophysiology of impaired ovarian function in galactosaemia. Hum Reprod Update. 2006;12:573–584
  26. Binart N, Helloco C, Ormandy CJ, Barra J, Clement-Lacroix P, Baran N, et al. Rescue of preimplantatory egg development and embryo implantation in prolactin receptor-deficient mice after progesterone administration. Endocrinology. 2000;141:2691–2697
  27. Binart N, Imbert-Bollore P, Baran N, Viglietta C, Kelly PA. A short form of the prolactin receptor is able to rescue mammopoiesis in heterozygous prolactin receptor mice. Mol Endocrinol. 2003;17:1066–1074
  28. Devi YS, Shehu A, Stocco C, Halperin J, Le J, Seibold AM, et al. Regulation of transcription factors and repression of Sp1 by prolactin signaling through the short isoform of its cognate receptor. Endocrinology. 2009;150:3327–3335
  29. Nagano M, Kelly PA. Tissue distribution and regulation of rat prolactin receptor gene expression: quantitative analysis by polymerase chain reaction. J Biol Chem. 1994;269:13337–13345
  30. Bachelot A, Binart N. Reproductive role of prolactin. Reproduction. 2007;133:361–369
  31. Binart N, Bachelot A, Bouilly J. Impact of prolactin receptor isoforms on reproduction. Trends Endocrinol Metab. 2010;21:362–368
  32. Lesueur L, Edery M, Ali S, Paly J, Kelly PA, Djiane J. Comparison of long and short forms of the prolactin receptor on prolactin induced milk protein gene transcription. Proc Natl Acad Sci U S A. 1991;88:824–828
  33. Berlanga JJ, Garcia-Ruiz JP, Perrot-Applanat M, Kelly PA, Edery M. The short form of the prolactin receptor silences prolactin induction of the β-casein gene promoter. Mol Endocrinol. 1997;11:1449–1457
  34. Perrot-Applanat M, Gualillo O, Pezet A, Vincent V, Edery M, Kelly PA. Dominant negative and cooperative effects of mutant forms of prolactin receptor. Mol Endocrinol. 1997;11:1020–1032
  35. Saunier E, Dif F, Kelly PA, Edery M. Targeted expression of the dominant-negative prolactin receptor in the mammary gland of transgenic mice results in impaired lactation. Endocrinology. 2003;144:2669–2675
  36. John GB, Gallardo TD, Shirley LJ, Castrillon DH. Foxo3 is a PI3K-dependent molecular switch controlling the initiation of oocyte growth. Dev Biol. 2008;321:197–204
  37. Reddy P, Liu L, Adhikari D, Jagarlamudi K, Rajareddy S, Shen Y, et al. Oocyte-specific deletion of Pten causes premature activation of the primordial follicle pool. Science. 2008;319:611–613
  38. Edson MA, Nagaraja AK, Matzuk MM. The mammalian ovary from genesis to revelation. Endocr Rev. 2009;30:624–712
  39. Schwarzler P, Untergasser G, Hermann M, Dirnhofer S, Abendstein B, Berger P. Prolactin gene expression and prolactin protein in premenopausal and postmenopausal human ovaries. Fertil Steril. 1997;68:696–701
  40. Vlahos NP, Bugg EM, Shamblott MJ, Phelps JY, Gearhart JD, Zacur HA. Prolactin receptor gene expression and immunolocalization of the prolactin receptor in human luteinized granulosa cells. Mol Hum Reprod. 2001;7:1033–1038
  41. Perks CM, Newcomb PV, Grohmann M, Wright RJ, Mason HD, Holly JM. Prolactin acts as a potent survival factor against C2-ceramide-induced apoptosis in human granulosa cells. Hum Reprod. 2003;18:2672–2677
  42. Bogorad RL, Courtillot C, Mestayer C, Bernichtein S, Harutyunyan L, Jomain JB, et al. Identification of a gain-of-function mutation of the prolactin receptor in women with benign breast tumors. Proc Natl Acad Sci U S A. 2008;105:14533–14538

 A.B. has nothing to disclose. J.B. has nothing to disclose. Y.L. has nothing to disclose. D.R. has nothing to disclose. C.L. has nothing to disclose. F.K. has nothing to disclose. P.T. has nothing to disclose. N.B. has nothing to disclose.

 This work was supported by Institut National de la Santé et de la Recherche Médicale. N.B. was awarded an Institut National de la Santé et de la Recherche Médicale–Assistance Publique–Hôpitaux de Paris Interface contract.

PII: S0015-0282(10)00993-3

doi: 10.1016/j.fertnstert.2010.06.040

Fertility and Sterility
Volume 94, Issue 7 , Pages 2772-2775 , December 2010

Article Tools

* Image Usage & Resolution